Alkermes, Inc.

Description: 

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. For more information, please visit Alkermes' website at www.alkermes.com

Exhibitor Level: 
Bronze Level
Booth Number: 
618
Exhibitor Type: 
Biotechnology Pharmaceuticals